These studies have generally used regular doses of psilocybin that produce euphoric and hallucinogenic effects. However, the use of regular doses of psilocybin can also produce unpleasant and terrifying experiences, also referred to as “bad trips”
https://buymushroomschocolatebars.com/shop/
In recent years, there has been a resurgence of scientific and popular interest in the potential use of psychedelic drugs for the treatment of depression, anxiety, and post-traumatic stress. For instance, psilocybin, the active ingredient in magic
mushrooms, has shownTrusted Source promise in the treatment of individuals with depression, anxiety, and substance use disorders.
Naturally occurring psychedelic substances such as psilocybin extract from magic mushrooms and mescaline have been used for their beneficial health effects for thousands of years.
The classification of psychedelic substances such as psilocybin and LSD as drugs of abuse without any medical use has, however, hindered research on the therapeutic effects of these substances.
https://buymushroomschocolatebars.com/product/3-5g-trippy-flip-milk-mushroom-chocolate-bars/
This has led to the adoption of a practice called microdosing,Trusted Source, which involves the consumption of small amounts of psychedelic substances that do not produce hallucinogenic effect
--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)